What Is a Certificate of Analysis? Definition and What Research Reports

Plain-language definition

A certificate of analysis (commonly abbreviated CoA) is a paper or electronic document that travels with a specific batch of a material and says, in effect: "here is what we tested, here is how we tested it, and here is what we found." It typically names the substance, gives a batch or lot number, lists each test performed (for example identity, purity, water content, residual solvents), states the acceptance limit for each test, and records the measured result. A CoA is a record of measurements already made on one lot — it is not a promise about a different lot, and it is not an approval by any government agency.

The everyday analogy is a lab report rather than a warranty. A CoA describes what an analyst observed on a particular day, using a particular method, on a particular sample drawn from a particular batch. Everything outside that scope — other lots, later degradation, storage conditions after shipping — is outside what the document can speak to.

This page is for educational purposes only and is not medical advice; consult a licensed physician or qualified professional for any health or research decision. Nothing here describes how any substance should be obtained, handled or administered.

What a CoA is in technical and regulatory terms

In compounding and pharmaceutical quality literature, the CoA functions as the documentary bridge between a supplier's testing and a user's incoming-material acceptance. A commentary in the compounding pharmacy literature framed the question directly — why a CoA is needed at all — and treated the document as part of routine material qualification rather than an optional extra (PMID 23050300).

In bioanalysis, the CoA has a more tightly defined role: it is the document that establishes the identity, purity and assigned content of a reference standard, which in turn underpins the accuracy of every concentration ever calculated against that standard. A consortium publication from the Global CRO Council for bioanalysis set out recommendations for what CoAs for reference standards should contain and how they should be managed over their lifecycle, including re-test and expiry handling (PMID 33847160). That paper illustrates an important point: the community found the content of CoAs variable enough that formal recommendations were considered useful.

Typical elements described in the literature

Certificates for certified reference materials

The most rigorous form of certificate accompanies a certified reference material (CRM), where the certificate reports assigned values derived from multiple independent analytical approaches together with an uncertainty statement. Published certification reports show how much work sits behind a single number on such a certificate.

For Standard Reference Material 1589a, researchers described the certification of polychlorinated biphenyls, pesticides, polybrominated diphenyl ethers and dioxins/furans in human serum, documenting the analytical work used to assign values to that material (PMID 17710387). A parallel report described the development and certification of SRM 695, a multi-nutrient fertiliser characterised for trace elements (PMID 17265084). In both cases the certificate was the published endpoint of an extensive measurement programme, not a quick screening result.

Certified materials are also used to test whether laboratories agree with each other. An inter-laboratory comparison evaluated ED-XRF and PIXE analytical techniques using filter-deposited multi-elemental certified reference materials representative of ambient particulate matter, comparing how different laboratories and techniques performed against the certified values (PMID 34030335). Studies of that design are the reason certificates carry uncertainty figures: measured values from different laboratories are not expected to be identical.

CoA data as a research dataset

Because CoAs are generated for every released lot, they accumulate into a long quantitative record. One pharmaceutical development study used quantitative CoA data specifically to assess how much excipient lot-to-lot variability had actually been sampled during drug product development — in other words, whether the lots used in development spanned the variability that the supplier's own certificates showed to exist (PMID 21877870). This treats the CoA not just as a release document but as data.

How the term is used in peptide research contexts

Research-grade peptide materials are frequently accompanied by documents labelled "certificate of analysis." In a laboratory setting the document is generally consulted for identity confirmation (commonly mass spectrometry), purity (commonly HPLC area percent), peptide content versus net weight, counter-ion and water content, and lot identification. The bioanalysis recommendations on reference-standard CoAs are directly relevant here, because a peptide used as an analytical standard requires an assigned content value before any quantitative result derived from it means anything (PMID 33847160).

Where the term is commonly misused

• Treated as a safety certification. A CoA reports analytical results. Nothing in the cited literature frames it as an assessment of safety, sterility for human use, or therapeutic suitability.
• Treated as regulatory approval. A certificate is issued by a laboratory or supplier, not by a regulator. Research-use-only materials remain research-use-only regardless of how thorough their paperwork is.
• Applied to the wrong lot. The document is lot-specific. Applying one lot's certificate to a different lot ignores exactly the variability that CoA-based studies were designed to quantify (PMID 21877870).
• Confused with a CRM certificate. A supplier CoA and a certificate for a certified reference material are different documents with different evidentiary weight; CRM certification involves formal value assignment and uncertainty estimation (PMID 17265084).
• Assumed to be uniform in content. The existence of published recommendations on CoA content implies the field observed inconsistency worth addressing (PMID 33847160).
• Read without checking scope. A purity figure is method-dependent; HPLC purity at one wavelength is not a statement about every possible impurity class.

Related terms

• Specification — the pre-agreed acceptance limits a result is compared against.
• Reference standard — a characterised material used to assign quantitative values in analysis; its CoA content and management were the subject of formal recommendations (PMID 33847160).
• Certified reference material (CRM) — a reference material with certified property values and stated uncertainties (PMID 17710387).
• Lot / batch — the defined quantity of material a certificate describes.
• Measurement uncertainty — the quantified doubt around a reported value.
• Inter-laboratory comparison — a study design in which multiple laboratories measure the same material, often a CRM, to assess agreement (PMID 34030335).
• Incoming material qualification — the process in which a CoA is one input (PMID 23050300).

What the published literature reports

Taken together, the verified literature supports a narrow set of statements. Researchers in compounding pharmacy described the CoA as a necessary part of material documentation rather than a formality (PMID 23050300). A bioanalysis consortium reported recommendations for CoA content and lifecycle management for reference standards (PMID 33847160). Certification reports documented the measurement programmes behind assigned values in human serum and fertiliser reference materials (PMID 17710387, PMID 17265084). An inter-laboratory study reported how analytical techniques compared when measured against certified materials (PMID 34030335). And a development study reported using quantitative CoA data to evaluate excipient lot-to-lot variability coverage (PMID 21877870).

What the cited literature does not report is any claim that a certificate of analysis establishes fitness for human administration. This page does not describe handling, preparation or administration of any substance, and no dosing information is presented.

References

• Why do I need a Certificate of Analysis? (International Journal of Pharmaceutical Compounding, 2012)
• Recommendations for the content and management of Certificates of Analysis for reference standards from the GCC for bioanalysis (Bioanalysis, 2021)
• Certification of SRM 1589a PCBs, pesticides, PBDEs, and dioxins/furans in human serum (Analytical and Bioanalytical Chemistry, 2007)
• Utilizing quantitative certificate of analysis data to assess the amount of excipient lot-to-lot variability sampled during drug product development (Pharmaceutical Development and Technology, 2013)
• Development and certification of the new SRM 695 trace elements in multi-nutrient fertilizer (Analytical and Bioanalytical Chemistry, 2007)
• Inter-laboratory comparison of ED-XRF/PIXE analytical techniques in the elemental analysis of filter-deposited multi-elemental certified reference materials representative of ambient particulate matter (Science of the Total Environment, 2021)